Publication
Characterization of plasma SDS-protein aggregation profile of patients with heart failure with preserved ejection fraction
dc.contributor.author | Gouveia, Marisol | |
dc.contributor.author | Schmidt, Cristine | |
dc.contributor.author | Teixeira, Manuel | |
dc.contributor.author | Lopes, Mário | |
dc.contributor.author | Aveiro, Susana | |
dc.contributor.author | Domingues, Pedro | |
dc.contributor.author | Xia, Ke | |
dc.contributor.author | Colón, Wilfredo | |
dc.contributor.author | Vitorino, Rui | |
dc.contributor.author | Ferreira, Rita | |
dc.contributor.author | Santos, Mário | |
dc.contributor.author | Vieira, Sandra | |
dc.contributor.author | Ribeiro, Fernando | |
dc.date.accessioned | 2023-01-23T15:26:12Z | |
dc.date.available | 2023-01-23T15:26:12Z | |
dc.date.issued | 2022 | |
dc.description.abstract | This study characterizes the plasma levels and composition of SDS-resistant aggregates (SRAs) in patients with heart failure with preserved ejection fraction (HFpEF) to infer molecular pathways associated with disease and/or proteostasis disruption. Twenty adults (ten with HFpEF and ten age-matched individuals) were included. Circulating SRAs were resolved by diagonal two-dimensional SDS-PAGE, and their protein content was identified by mass spectrometry. Protein carbonylation, ubiquitination and ficolin-3 were evaluated. Patients with HFpEF showed higher SRA/total (36.6 +/- 4.9% vs 29.6 +/- 2.2%, p = 0.009) and SRA/soluble levels (58.6 +/- 12.7% vs 40.6 +/- 5.8%, p = 0.008). SRAs were carbonylated and ubiquitinated, suggesting they are composed of dysfunctional proteins resistant to degradation. SRAs were enriched in proteins associated with cardiovascular function/disease and with proteostasis machinery. Total ficolin-3 levels were decreased (0.77 +/- 0.22, p = 0.041) in HFpEF, suggesting a reduced proteostasis capacity to clear circulating SRA. Thus, the higher accumulation of SRA in HFpEF may result from a failure or overload of the protein clearance machinery. | pt_PT |
dc.description.sponsorship | BEX0554/14-6 | |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.1007/s12265-022-10334-w | pt_PT |
dc.identifier.eissn | 1937-5395 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/18896 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Springer | pt_PT |
dc.relation | Unit for Multidisciplinary Research in Biomedicine | |
dc.relation | Unit for Multidisciplinary Research in Biomedicine | |
dc.relation | Analysis of protein aggregation in plasma of patients with heart failure with preserved ejection fraction to find novel therapeutic targets and monitor therapeutic interventions | |
dc.relation | Targeting pulmonary artery endothelial cells dysfunction in pulmonary arterial hypertension: in situ assessment of the effects of acute exercise | |
dc.subject | Cardiovascular disease | pt_PT |
dc.subject | Proteostasis | pt_PT |
dc.subject | Aggregates | pt_PT |
dc.subject | Mass spectrometry | pt_PT |
dc.subject | Bioinformatics | pt_PT |
dc.title | Characterization of plasma SDS-protein aggregation profile of patients with heart failure with preserved ejection fraction | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Unit for Multidisciplinary Research in Biomedicine | |
oaire.awardTitle | Unit for Multidisciplinary Research in Biomedicine | |
oaire.awardTitle | Analysis of protein aggregation in plasma of patients with heart failure with preserved ejection fraction to find novel therapeutic targets and monitor therapeutic interventions | |
oaire.awardTitle | Targeting pulmonary artery endothelial cells dysfunction in pulmonary arterial hypertension: in situ assessment of the effects of acute exercise | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00215%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00215%2F2020/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/POR_CENTRO/SFRH%2FBD%2F128893%2F2017/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/POR_CENTRO/2020.08565.BD/PT | |
oaire.citation.title | Journal of Cardiovascular Translational Research | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | 6817 - DCRRNI ID | |
oaire.fundingStream | POR_CENTRO | |
oaire.fundingStream | POR_CENTRO | |
person.familyName | Aveiro | |
person.givenName | Susana | |
person.identifier.ciencia-id | D312-07B4-DA74 | |
person.identifier.orcid | 0000-0002-6651-3226 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | ed8b83e5-9fb0-4701-a65e-90690ccc139c | |
relation.isAuthorOfPublication.latestForDiscovery | ed8b83e5-9fb0-4701-a65e-90690ccc139c | |
relation.isProjectOfPublication | 23f88acf-6c29-4c4d-9321-9d0a491e644f | |
relation.isProjectOfPublication | 5da0b1ac-b581-419c-b074-65ec5e8ba043 | |
relation.isProjectOfPublication | 04d18d6d-71d3-40f1-a5dc-04bbf7738a4b | |
relation.isProjectOfPublication | d6d26ccf-3799-4f0a-a705-e9ad27e50366 | |
relation.isProjectOfPublication.latestForDiscovery | 23f88acf-6c29-4c4d-9321-9d0a491e644f |